| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |